Recent News

Symposium’23 Program
“Innovative drugs & health products,
imaging & theranostics agents –
cell & gene biotherapies”, March 17, 2023, 13:30
Program here.
3e matinée Carnot Star “9-12 Recherche-Industrie” dédiée à l’Imagerie, 17 Mars 2023, 8h30
Programme ici, inscriptions ici, .
FairEmbo en Afrique : “Ce médecin marseillais sauve des femmes avec des bouts de ficelle”
FairEmbo en Afrique : l’Embolisation-pour-tous franchit une nouvelle étape. Plus d’informations ici.
Webinar: Discover Radiotheranostics in Nuclear Medicine (15 Sept. 2022)
Plus d’informations ici.
Le projet EmboBio, développé au CERIMED, a reçu le prix de l’innovation AP-HM 2022
Plus d’informations sur le prix AP-HM de l’innovation 2022 ici. Plus d’informations sur le projet Embobio dans cette vidéo.
Le CERIMED obtient la double certification ISO 9001:2015 et NF X50-900:2016 pour ses activités de prestation et d’innovation radiologiques et nucléaires pré-cliniques
Le Centre Européen de Recherche en Imagerie Médicale (CERIMED, UMS AMU CNRS 2012) a obtenu le 5 juin 2022 la double certification ISO 9001:2015 et NF-X50-900:2016 pour
Symposium’21 Program
“Innovative drugs & health products,
imaging & theranostics agents –
cell & gene biotherapies”
Program here.
VECT-HORUS and CERIMED Announce Collaboration to Support the Development of VECT-HORUS’ Theragnostic Agents
VECT-HORUS, a biotechnology company that designs and develops vectors that facilitate the targeted delivery of therapeutic molecules and imaging agents, has announced the signing of a collaboration
FAIR-Embo hopes to spread safe, cheap embolization around the world
We are proud to anounce that Pr Vincent Vidal (Marseille, France), Head of the Experimental Interventional Radiology Laboratory hosted at CERIMED, and colleagues have demonstrated the in vivo feasibility

Last Publications (10/405)

Roussel, T, Cruz-Dubois, T, Louis, B, Laurini, E, Ding, L, Balasse, L et al.. Impact of inner hydrophobicity of dendrimer nanomicelles on biodistribution: a PET imaging study. J Mater Chem B. 2024; :. doi: 10.1039/d4tb01266f. PubMed PMID:39699216 .
Escarrat, V, Reato, D, Blivet, G, Touchon, J, Rougon, G, Bos, R et al.. Dorsoventral photobiomodulation therapy safely reduces inflammation and sensorimotor deficits in a mouse model of multiple sclerosis. J Neuroinflammation. 2024;21 (1):321. doi: 10.1186/s12974-024-03294-2. PubMed PMID:39696356 PubMed Central PMC11656913.
Rozenblum, L, Debroucker, T, Habert, MO, Soret, M, Desarnaud, S, Lemercier, VC et al.. Cognitive Impairment and Brain Metabolic Changes in Post-Acute Sequelae of COVID-19: Insights From an [18F]FDG PET/CT Cohort Study. Clin Nucl Med. 2024; :. doi: 10.1097/RLU.0000000000005614. PubMed PMID:39690505 .
Berti, V, Fasciglione, E, Charpiot, A, Montanini, F, Pepponi, M, Leo, A et al.. Deciphering ¹⁸F-DOPA uptake in SDH-related head and neck paragangliomas: a radiomics approach. J Endocrinol Invest. 2024; :. doi: 10.1007/s40618-024-02515-y. PubMed PMID:39666255 .
Couvreur, U, Gallet, Q, Campion, JY, Brizard, B, Réméniéras, JP, Gissot, V et al.. Elevated brain pulsations in depression: insights from a pooled ultrasound cohort study. Interface Focus. 2024;14 (6):20240028. doi: 10.1098/rsfs.2024.0028. PubMed PMID:39649448 PubMed Central PMC11620821.
González Torrecilla, S, Delbrel, A, Giacomino, L, Meunier, D, Sein, J, Renaud, L et al.. Long lasting argon neuroprotection in a non-human primate model of transient endovascular ischemic stroke. J Cereb Blood Flow Metab. 2024; :271678X241297798. doi: 10.1177/0271678X241297798. PubMed PMID:39628320 PubMed Central PMC11615904.
Bastiancich, C, Snacel-Fazy, E, Fernandez, S, Robert, S, Stacchini, R, Plantureux, L et al.. Tailoring glioblastoma treatment based on longitudinal analysis of post-surgical tumor microenvironment. J Exp Clin Cancer Res. 2024;43 (1):311. doi: 10.1186/s13046-024-03231-4. PubMed PMID:39605004 PubMed Central PMC11603899.
Bobot, M, Burtey, S. New insights into mechanisms underlying cognitive impairment in chronic kidney disease. Kidney Int. 2024;106 (6):1020-1022. doi: 10.1016/j.kint.2024.09.008. PubMed PMID:39577985 .
Rogeau, A, Boer, AJ, Guedj, E, Sala, A, Sommer, IE, Veronese, M et al.. EANM perspective on clinical PET and SPECT imaging in schizophrenia-spectrum disorders: a systematic review of longitudinal studies. Eur J Nucl Med Mol Imaging. 2024; :. doi: 10.1007/s00259-024-06987-1. PubMed PMID:39576337 .
Castelli, M, Maurin, A, Bartoli, A, Dassa, M, Marchi, B, Finance, J et al.. Author Correction: Prevalence and risk factors for lung involvement on low-dose chest CT (LDCT) in a paucisymptomatic population of 247 patients affected by COVID-19. Insights Imaging. 2024;15 (1):266. doi: 10.1186/s13244-024-01847-w. PubMed PMID:39514137 PubMed Central PMC11549255.

Search PubMed

Dernières Publications (10/405)

Roussel, T, Cruz-Dubois, T, Louis, B, Laurini, E, Ding, L, Balasse, L et al.. Impact of inner hydrophobicity of dendrimer nanomicelles on biodistribution: a PET imaging study. J Mater Chem B. 2024; :. doi: 10.1039/d4tb01266f. PubMed PMID:39699216 .
Escarrat, V, Reato, D, Blivet, G, Touchon, J, Rougon, G, Bos, R et al.. Dorsoventral photobiomodulation therapy safely reduces inflammation and sensorimotor deficits in a mouse model of multiple sclerosis. J Neuroinflammation. 2024;21 (1):321. doi: 10.1186/s12974-024-03294-2. PubMed PMID:39696356 PubMed Central PMC11656913.
Rozenblum, L, Debroucker, T, Habert, MO, Soret, M, Desarnaud, S, Lemercier, VC et al.. Cognitive Impairment and Brain Metabolic Changes in Post-Acute Sequelae of COVID-19: Insights From an [18F]FDG PET/CT Cohort Study. Clin Nucl Med. 2024; :. doi: 10.1097/RLU.0000000000005614. PubMed PMID:39690505 .
Berti, V, Fasciglione, E, Charpiot, A, Montanini, F, Pepponi, M, Leo, A et al.. Deciphering ¹⁸F-DOPA uptake in SDH-related head and neck paragangliomas: a radiomics approach. J Endocrinol Invest. 2024; :. doi: 10.1007/s40618-024-02515-y. PubMed PMID:39666255 .
Couvreur, U, Gallet, Q, Campion, JY, Brizard, B, Réméniéras, JP, Gissot, V et al.. Elevated brain pulsations in depression: insights from a pooled ultrasound cohort study. Interface Focus. 2024;14 (6):20240028. doi: 10.1098/rsfs.2024.0028. PubMed PMID:39649448 PubMed Central PMC11620821.
González Torrecilla, S, Delbrel, A, Giacomino, L, Meunier, D, Sein, J, Renaud, L et al.. Long lasting argon neuroprotection in a non-human primate model of transient endovascular ischemic stroke. J Cereb Blood Flow Metab. 2024; :271678X241297798. doi: 10.1177/0271678X241297798. PubMed PMID:39628320 PubMed Central PMC11615904.
Bastiancich, C, Snacel-Fazy, E, Fernandez, S, Robert, S, Stacchini, R, Plantureux, L et al.. Tailoring glioblastoma treatment based on longitudinal analysis of post-surgical tumor microenvironment. J Exp Clin Cancer Res. 2024;43 (1):311. doi: 10.1186/s13046-024-03231-4. PubMed PMID:39605004 PubMed Central PMC11603899.
Bobot, M, Burtey, S. New insights into mechanisms underlying cognitive impairment in chronic kidney disease. Kidney Int. 2024;106 (6):1020-1022. doi: 10.1016/j.kint.2024.09.008. PubMed PMID:39577985 .
Rogeau, A, Boer, AJ, Guedj, E, Sala, A, Sommer, IE, Veronese, M et al.. EANM perspective on clinical PET and SPECT imaging in schizophrenia-spectrum disorders: a systematic review of longitudinal studies. Eur J Nucl Med Mol Imaging. 2024; :. doi: 10.1007/s00259-024-06987-1. PubMed PMID:39576337 .
Castelli, M, Maurin, A, Bartoli, A, Dassa, M, Marchi, B, Finance, J et al.. Author Correction: Prevalence and risk factors for lung involvement on low-dose chest CT (LDCT) in a paucisymptomatic population of 247 patients affected by COVID-19. Insights Imaging. 2024;15 (1):266. doi: 10.1186/s13244-024-01847-w. PubMed PMID:39514137 PubMed Central PMC11549255.

Search PubMed